JN-INTERNATIONAL MEDICAL CORP

Organization: JN is a global research-based company that develops and markets products to protect from Malaria, TB, HIV and Bacterial meningitis diseases in more than 30 developing countries since 1998. Now, JN is a leading innovation-driven Biopharmaceutical orporation. JN stands 3rd in the World developed Meningococcal meningitis groups A, C, Y, W-135 polysaccharide vaccine for adults & children and stands 2nd in the World in providing Meningitis A, C, Y, W-135 Diphtheria conjugate meningococcal vaccine for all ages. JN is a partner of Global Health Organization such as Clinton Global Initiative, and GBC. JN also partnering with several other non-profit global health organizations, NGOs, local governments and communities in developing countries to address the health issues related to HIV / AIDS, Malaria, Tuberculosis and Bacterial Meningitis by underserved communities in West Africa, South East Asia and Latin Americas. Global Presence: The Corporation opened its first overseas branch in 2005 in Abidjan, Ivory Coast and later in 2006 in Ouagadougou, Burkina Faso. This year (2008) first South East Asia branch opened in Malaysia. Operating in Africa and Asia enables the company to more efficiently distribute many of its products to resource-poor communities. Research, Development and Patenting: JN developing vaccines for prevention and cure for Hepatitis C, Herpes, Tuberculosis and Stroke, Epilepsy and Parkinson's disease. While research and development and clinical trials are in its way, we filed patents to protect our intellectual properties of our years work and investment.

Related Suppliers By Main Products